H.R. 124: Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Latest action, January 3, 2025: Introduced in House
Official summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)